Hearing News Watch

TARRYTOWN, NEW YORK – Regeneron Pharmaceuticals, Inc. reported promising safety and efficacy outcomes from the first patient under the age of two enrolled in the Phase 1/2 CHORD trial. This trial focuses on otoferlin gene therapy (DB-OTO) for children with profound genetic hearing loss stemming from otoferlin gene mutations. Children with profound hearing loss due to otoferlin gene mutations face

MILAN, ITALY — The possibilities offered by cutting-edge scientific knowledge for assessing hearing loss, complementing traditional audiometric tests, and addressing the challenges of tinnitus were the central themes of the “What the Audiogram doesn’t tell us” Congress. This two-day, in-depth scientific event concluded last Saturday in Lisbon, bringing together ENT-audiologists from Italy, France, Spain, and Portugal, with generous support from

EDEN PRAIRIE, MINNESOTA – Starkey has been named to Inc. Magazine’s 2023 Power Partner list. This prestigious distinction recognizes reliable business-to-business organizations that care as much for a client’s business as they do their own. Winners were selected based largely on feedback directly from customers. “Starkey’s mission is to serve our customers better than anyone else, but there’s a much deeper

Excessive noise exposure, often dismissed as a mere annoyance, is being brought into the spotlight as a significant yet underrecognized public health concern, especially for children and adolescents. According to a report recently released by the American Academy of Pediatrics (AAP), as many as 12.5% of children and teenagers aged 6-19 may be at risk of permanent hearing damage due

ADELAIDE, AUSTRALIA — Despite a substantial surge in the adoption of telehealth during the COVID-19 pandemic, a recent study by Flinders University suggests that the potential of telehealth-supported access to audiologists remains underutilized, citing concerns about trust in the system. Lead author Boaz Mui, a PhD student at the College of Education, Psychology, and Social Work, highlights the industry’s positive

WHITE BEAR LAKE, MINNESOTA — A recent clinical publication in the Journal of Clinical Medicine (JCM) highlighted early surgical experience with Envoy Medical®, Inc.’s investigational Acclaim® fully implantable cochlear implant. According to the publication: “All three surgeries proceeded without complication, and at activation, all three patients were hearing through their devices. Surgery is more technically challenging compared to a standard

THOUSAND OAKS, CALIFORNIA — California Lutheran University has been granted a substantial $1,241,679 award by the U.S. Department of Education to bolster its Graduate School of Education’s Deaf and Hard of Hearing Credential Program. The five-year grant will fund “Access Teach: Closing the Deaf/Hard of Hearing Educator Gap,” a project that aims to support 60 graduate-level students as they prepare

BOSTON, MASSACHUSSETTS – A year after the introduction of over-the-counter (OTC) hearing aids for Americans with mild to moderate hearing loss, a significant knowledge gap persists regarding the potential health consequences of untreated hearing loss, according to a new survey conducted by The Harris Poll on behalf of Lexie Hearing. The survey, which was released today, involved more than 1,000

SOMERSET, NEW JERSEY – Over 40 employees from Demant came together to participate in the Mary’s Place by the Sea Annual Walk-a-Thon, showing their support for the valuable work of the nonprofit respite home dedicated to women battling cancer. Members of the Demant Care Community, along with other Demant employees, took to the streets in Ocean Grove, New Jersey, and joined

LONG BEACH, CALIFORNIA – JVCKenwood today announced plans to enter the over-the-counter (OTC) hearing aid market, partnering with hearing health specialists  at Intricon Corporation and hearing aid technology company, Tuned Ltd. JVCKenwood will offer JVC OTC hearing aids developed jointly with Intricon and Tuned, capitalizing on JVC’s decades of experience in high quality sound reproduction. “The recent approval by the